Literature DB >> 25060293

Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.

David F Tough1, Huw D Lewis, Inmaculada Rioja, Matthew J Lindon, Rab K Prinjha.   

Abstract

The properties of a cell are determined both genetically by the DNA sequence of its genes and epigenetically through processes that regulate the pattern, timing and magnitude of expression of its genes. While the genetic basis of disease has been a topic of intense study for decades, recent years have seen a dramatic increase in the understanding of epigenetic regulatory mechanisms and a growing appreciation that epigenetic misregulation makes a significant contribution to human disease. Several large protein families have been identified that act in different ways to control the expression of genes through epigenetic mechanisms. Many of these protein families are finally proving tractable for the development of small molecules that modulate their function and represent new target classes for drug discovery. Here, we provide an overview of some of the key epigenetic regulatory proteins and discuss progress towards the development of pharmacological tools for use in research and therapy.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25060293      PMCID: PMC4253452          DOI: 10.1111/bph.12848

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  289 in total

Review 1.  Role of histone acetylation in cell physiology and diseases: An update.

Authors:  Shahper N Khan; Asad U Khan
Journal:  Clin Chim Acta       Date:  2010-06-23       Impact factor: 3.786

2.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

3.  Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.

Authors:  Myles B C Dillon; Daniel A Bachovchin; Steven J Brown; M G Finn; Hugh Rosen; Benjamin F Cravatt; Kerri A Mowen
Journal:  ACS Chem Biol       Date:  2012-04-20       Impact factor: 5.100

Review 4.  Sorting out functions of sirtuins in cancer.

Authors:  M Roth; W Y Chen
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

5.  Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.

Authors:  June X Zou; Linlang Guo; Alexey S Revenko; Clifford G Tepper; Abigael T Gemo; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

6.  Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities.

Authors:  Sheila K Pirooznia; Felice Elefant
Journal:  Front Cell Neurosci       Date:  2013-03-28       Impact factor: 5.505

7.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

8.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

9.  H4K20 methylation regulates quiescence and chromatin compaction.

Authors:  Adam G Evertts; Amity L Manning; Xin Wang; Nicholas J Dyson; Benjamin A Garcia; Hilary A Coller
Journal:  Mol Biol Cell       Date:  2013-08-07       Impact factor: 4.138

10.  A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.

Authors:  Vincenzo Libri; Andrew P Brown; Giulio Gambarota; Jonathan Haddad; Gregory S Shields; Helen Dawes; David J Pinato; Ethan Hoffman; Peter J Elliot; George P Vlasuk; Eric Jacobson; Martin R Wilkins; Paul M Matthews
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more
  10 in total

Review 1.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 2.  Epigenetic drug discovery: breaking through the immune barrier.

Authors:  David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal:  Nat Rev Drug Discov       Date:  2016-10-21       Impact factor: 84.694

Review 3.  The Molecular Revolution in Cutaneous Biology: Chromosomal Territories, Higher-Order Chromatin Remodeling, and the Control of Gene Expression in Keratinocytes.

Authors:  Vladimir A Botchkarev
Journal:  J Invest Dermatol       Date:  2017-05       Impact factor: 8.551

Review 4.  Epigenetic control of adult stem cell function.

Authors:  Alexandra Avgustinova; Salvador Aznar Benitah
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-13       Impact factor: 94.444

5.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971

Review 6.  The contributions of cancer cell metabolism to metastasis.

Authors:  Gloria Pascual; Diana Domínguez; Salvador Aznar Benitah
Journal:  Dis Model Mech       Date:  2018-05-03       Impact factor: 5.758

Review 7.  Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.

Authors:  Cristina Municio; Gabriel Criado
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 8.  Prophylactic and therapeutic insights into trained immunity: A renewed concept of innate immune memory.

Authors:  Suresh Bindu; Satyabrata Dandapat; Rajendran Manikandan; Murali Dinesh; Anbazhagan Subbaiyan; Pashupathi Mani; Manish Dhawan; Ruchi Tiwari; Muhammad Bilal; Talha Bin Emran; Saikat Mitra; Ali A Rabaan; Abbas Al Mutair; Zainab Al Alawi; Saad Alhumaid; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

9.  Inhibition of DNA Methylation With Zebularine Alters Lipopolysaccharide-Induced Sickness Behavior and Neuroinflammation in Mice.

Authors:  Stephanie M Matt; Jalisa D Zimmerman; Marcus A Lawson; Angela C Bustamante; Monica Uddin; Rodney W Johnson
Journal:  Front Neurosci       Date:  2018-09-18       Impact factor: 4.677

10.  Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.

Authors:  Ian J Groves; Sarah E Jackson; Emma L Poole; Aharon Nachshon; Batsheva Rozman; Michal Schwartz; Rab K Prinjha; David F Tough; John H Sinclair; Mark R Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.